Scientific Symposium

KSF hosts an annual Scientific Symposium for the research community to foster collaborations, encourage knowledge-sharing, and enable professionals to share their latest findings related to Kabuki syndrome.

A summary of the virtual meeting held on October 26, 2023 is now available. The 2023 Symposium featured four themes and was facilitated by KSF’s Chief Scientific Officer, Dr. Bruce Bloom, and Director of Research, Dr. Clara Tang. Register below to be notified of our next event!

Sign Up for Updates

Symposium Summary Available

We hosted over 60 clinicians, researchers and investigators at the 2023 KSF Scientific Symposium on Thursday, October 26th, 2023.

This event marked an opportunity to interact with some of the Kabuki syndrome community’s best minds, including members of our distinguished Medical Advisory Board. Attendees dove deeper into the latest Kabuki syndrome research, forged valuable collaborations, and gained enlightening insights into their own research and practice.

The symposium featured 10-minute oral virtual presentations on the following four themes, followed by Q&A:

  • Genetics and epigenetics: explore the genetic and epigenetic mechanisms underlying Kabuki syndrome, including functions of KMT2D and KDM6A and the molecular pathways that are affected.
  • Kabuki syndrome phenotypes: the latest insights on the pathways and mechanisms underlying neurological, immune and metabolic features of Kabuki syndrome.
  • Therapeutic opportunities: potential pharmacological interventions and the latest advances in treatment strategies for Kabuki syndrome.
  • Diagnosis and clinical trial readiness: recent research on diagnostic methods, biomarkers and outcome measures development.

Read the summary below and reach out to KSF’s Director of Research, Dr. Clara Tang, with any questions.